THE PROGNOSTIC IMPACT OF CONCORDANT AND DISCORDANT BONE MARROW INVOLVEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA, INDEPENDENT OF THE REVISED INTERNATIONAL PROGNOSTIC INDEX AND CELL OF ORIGIN

被引:0
|
作者
Park, M. [1 ]
Park, P. [1 ]
Seo, Y. [1 ]
Kim, K. [1 ]
Jeong, J. [1 ]
Kim, M. [1 ]
Ahn, J. [1 ]
Lee, J. [2 ]
Park, J. [2 ]
Hong, J. [2 ]
Kim, H. [3 ]
机构
[1] Gachon Univ, Gil Med Ctr, Lab Med, Incheon, South Korea
[2] Gachon Univ, Gil Med Ctr, Internal Med, Incheon, South Korea
[3] Chung Ang Univ, Coll Med, Lab Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P342
引用
收藏
页码:147 / 147
页数:1
相关论文
共 50 条
  • [41] The Sil Index Is a Useful Prognostic Indicator for Diffuse Large B-Cell Lymphoma
    Tomita, Naoto
    Suzuki, Taisei
    Miyashita, Kazuho
    Yamamoto, Wataru
    Motohashi, Kenji
    Tachibana, Takayoshi
    Takasaki, Hirotaka
    Kawasaki, Rika
    Hagihara, Maki
    Hashimoto, Chizuko
    Takemura, Sachiya
    Koharazawa, Hideyuki
    Yamazaki, Etsuko
    Taguchi, Jun
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Sakai, Rika
    Fujisawa, Shin
    Motomura, Shigeki
    Kawamoto, Keisuke
    Sone, Hirohito
    Takizawa, Jun
    BLOOD, 2015, 126 (23)
  • [42] The International Prognostic Index in aggressive B-cell lymphoma
    Maurer, Matthew J.
    HAEMATOLOGICA, 2023, 108 (11) : 2878 - 2879
  • [43] Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin: Seeing the Forest and the Trees
    Younes, Anas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) : 2835 - +
  • [44] Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma
    Go, Se-Il
    Park, Sungwoo
    Kang, Myoung Hee
    Kim, Hoon-Gu
    Kim, Hye Ree
    Lee, Gyeong-Won
    ANNALS OF HEMATOLOGY, 2019, 98 (02) : 401 - 411
  • [45] Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma
    Se-Il Go
    Sungwoo Park
    Myoung Hee Kang
    Hoon-Gu Kim
    Hye Ree Kim
    Gyeong-Won Lee
    Annals of Hematology, 2019, 98 : 401 - 411
  • [46] CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF BONE-MARROW INVOLVEMENT IN PATIENTS WITH DIFFUSE AGGRESSIVE B-CELL LYMPHOMA
    YAN, Y
    CHAN, WC
    WEISENBURGER, DD
    ANDERSON, JR
    BAST, MA
    VOSE, JM
    BIERMAN, PJ
    ARMITAGE, JO
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (06) : 1336 - 1342
  • [47] Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma
    Cerei, Juliano J.
    Gyorke, Tamas
    Fanti, Stefano
    Paez, Diana
    Meneghetti, Jose Claudio
    Redondo, Francisca
    Celli, Monica
    Auewarakul, Chirayu
    Rangarajan, Venkatesh
    Gujral, Sumeet
    Gorospe, Charity
    Campo, Maejoy V.
    Chung, June-Key
    Morris, Tim P.
    Dondi, Maurizio
    Carr, Robert
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (10) : 1591 - 1597
  • [48] Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact
    Devin, Julie
    Kassambara, Alboukadel
    Bruyer, Angelique
    Moreaux, Jerome
    Bret, Caroline
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07)
  • [49] Both discordant and concordant bone marrow (BM) involvement predict for a poorer outcome independent of the IPI in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP
    Sehn, Laurie H.
    Chhanabhai, Mukesh
    Singh, Suman
    Saville, Wayne
    Matso, Dan
    Spinelli, John J.
    Connors, Joseph M.
    Gascoyne, Randy D.
    BLOOD, 2007, 110 (11) : 466A - 466A
  • [50] Prognostic impact of MYD88 mutation, proliferative index and cell origin in diffuse large B cell lymphoma
    Fogliatto, Laura
    Grokoski, Kamila Castro
    Strey, Yuri Machado
    Vanelli, Tito
    da Silva Fraga, Christina Garcia
    Barra, Marines Bizarro
    Pinto, Fernanda Correa
    Bendit, Israel
    Bica, Claudia Giuliano
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2019, 41 (01) : 50 - 56